Consistent with this finding, we showed that YTHDC1 inhibited the glycolytic process in bladder cancer cells by influencing the mRNA stability of GLUT3 in an m6A modification-dependent manner. The gene discussed is SLC2A3; the disease is urinary bladder cancer.